Excipient for Inhalation

Repurposing drugs such as the FDA-approved niclosamide is a highly efficient way to leverage drugs with known safety profiles to...

Respiratory diseases account for a very significant portion of worldwide morbidity and mortality but to-date only a limited number of...

Although dry powder inhalers (DPIs) have attracted great interest compared to nebulizers and metered-dose inhalers (MDIs), drug deposition in the...

Background and objective: Dry powder inhalation provide many promising features for drug delivery to the pulmonary system, such as localization...

Building on a long and well established history of supplying world class pharmaceutical grade lactose, film coatings, and tableting systems,...

Background The use of amino acids as excipients is a promising approach to improve the physical stability and powder dispersibility...

Non-segregating ordered powder mixtures constituted by a coarse carrier fraction and finer components are at the basis of dry powders for...

Localized aerosol delivery of gene therapies is a promising treatment of severe pulmonary diseases including lung cancer, cystic fibrosis, COPD...

This chapter describes the application of lactose as excipient in the pharmaceutical industry. About 60%–70% of pharmaceutical dosage forms contain...

This study describes the development and characterization of glucagon dry powder inhaler (DPI) formulation for pulmonary delivery. Lactose monohydrate, as...